Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement

• Natalie Berghaus ,

  Roles Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

  * E-mail: stefanie.huhn@med.uni-heidelberg.de (SH); natalie.berghaus@med.uni-heidelberg.de (NB)

  Affiliation Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  https://orcid.org/0000-0002-5791-698X

  ⨯
• Sarah Schreiner,

  Roles Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Martin Granzow,

  Roles Resources, Writing – review & editing

  Affiliation Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Carsten Müller-Tidow,

  Roles Resources, Writing – review & editing

  Affiliations Medical Department V, Heidelberg University Hospital, Heidelberg, Germany, National Centre for Tumor Diseases (NCT), Heidelberg, Germany

  ⨯
• Ute Hegenbart,

  Roles Conceptualization, Funding acquisition, Project administration, Resources, Writing – review & editing

  Affiliation Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Stefan O. Schönland,

  Roles Conceptualization, Funding acquisition, Project administration, Resources, Writing – review & editing

  Affiliation Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Stefanie Huhn

  Roles Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing

  * E-mail: stefanie.huhn@med.uni-heidelberg.de (SH); natalie.berghaus@med.uni-heidelberg.de (NB)

  Affiliation Medical Department V, Section of Multiple Myeloma, Heidelberg University Hospital, Heidelberg, Germany

  ⨯